Anticoagulation control and major adverse clinical events in patients with operated valvular heart disease with and without atrial fibrillation receiving vitamin K …
Background: Good quality anticoagulation among patients with operated valvular heart
disease is needed to reduce ischaemic and thromboembolic complications. There is limited …
disease is needed to reduce ischaemic and thromboembolic complications. There is limited …
[PDF][PDF] Designing a Device to Mechanically Stretch Cultured Heart Valve Microtissues
MV de Franca Araujo - 2020 - digital.wpi.edu
Tissue engineered heart valves are a promising solution to current problems with heart
valve replacements. However, TEHVs contract when implanted. This project aims to design …
valve replacements. However, TEHVs contract when implanted. This project aims to design …
Anticoagulation control in patients with atrial fibrillation
HHB Zulkifly - 2019 - etheses.bham.ac.uk
To examine self-reported depression, anxiety, beliefs about medication, knowledge of AF,
and quality of life in newly anticoagulated atrial fibrillation (AF) patients and to investigate …
and quality of life in newly anticoagulated atrial fibrillation (AF) patients and to investigate …